Wisderm.com
Open menu
Concerns
Interventions
Latest Research
FAQ
Effect of Eucerin Anti-Pigment Dual Serum + Eucerin Anti-Pigment Day SPF30 + Eucerin Anti-Pigment Night on Skin Brightness
Efficacy
Study
Method
Effect
Description
Study Outcomes
Thiamidol® in moderate-to-severe melasma: 24-week, randomized, double-blind, vehicle-controlled clinical study with subsequent regression phase
Chromameter
–
Sign in to read for free
Thiamidol® in moderate-to-severe melasma: 24-week, randomized, double-blind, vehicle-controlled clinical study with subsequent regression phase
Sign in to read for free
Effective reduction of post-inflammatory hyperpigmentation with the tyrosinase inhibitor isobutylamido-thiazolyl-resorcinol (Thiamidol)
Mexameter
–
Sign in to read for free
Effective reduction of post-inflammatory hyperpigmentation with the tyrosinase inhibitor isobutylamido-thiazolyl-resorcinol (Thiamidol)
Sign in to read for free
Thiamidol containing treatment regimens in facial hyperpigmentation: An international multi-centre approach consisting of a double-blind, controlled, split-face study and of an open-label, real-world study
Chromameter
⇧
Sign in to read for free
Thiamidol containing treatment regimens in facial hyperpigmentation: An international multi-centre approach consisting of a double-blind, controlled, split-face study and of an open-label, real-world study
Sign in to read for free
A double-blind randomised controlled trial - the gold standard
A human study that doesn't meet the gold standard
A case report or a study conducted on animals, tissues, or cells
Latest Research
Thiamidol® in moderate-to-severe melasma: 24-week, randomized, double-blind, vehicle-controlled clinical study with subsequent regression phase (2021)
See study outcomes
Sign in to read for free
Effective reduction of post-inflammatory hyperpigmentation with the tyrosinase inhibitor isobutylamido-thiazolyl-resorcinol (Thiamidol) (2021)
See study outcomes
Sign in to read for free
Thiamidol containing treatment regimens in facial hyperpigmentation: An international multi-centre approach consisting of a double-blind, controlled, split-face study and of an open-label, real-world study (2020)
See study outcomes
Sign in to read for free